Get the Stockscreener App
6.3954
0.47%
-0.0446
Fulcrum Therapeutics Inc Stock (FULC) Forecast
The Fulcrum Therapeutics Inc (FULC) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.86, representing a +132.31% increase from the current price of $6.3954. The highest analyst price target is $17.46, and the lowest is $12.26.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FULC Price Target
Average 9.8802
(+54.49% Upside)
Is Fulcrum Therapeutics Inc (FULC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 65.49 | Neutral |
| STOCH(9,6) | 63.59 | Neutral |
| STOCHRSI(14) | 7.8947 | Buy |
| MACD(12,26) | 0.7165 | Sell |
| ADX(14) | 55.47 | Buy |
| William %R | -31.29 | Neutral |
| CCI(14) | 25.32 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.3495
Sell
|
6.1941
Buy
|
| MA20 |
5.6803
Buy
|
5.6628
Buy
|
| MA50 |
4.1006
Buy
|
4.6863
Buy
|
| MA100 |
3.9652
Buy
|
4.336
Buy
|
| MA200 |
4.4353
Buy
|
4.8828
Buy
|
Buy: 9
Sell: 1
Neutral: 0
Summary: Buy
According to our latest analysis, FULC could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on FULC, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 65.49 indicates that FULC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 63.59 indicates that FULC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 7.8947 indicates that FULC is oversold. This suggests that FULC price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 55.47 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 25.32 indicates that FULC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FULC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Fulcrum Therapeutics Inc financial reports and earnings history, Fulcrum Therapeutics Inc (FULC) stock could reach $4.7606 by 2030, $6.2004 by 2040 and $10.55 by 2050. See the projected annual prices until 2050 of the Fulcrum Therapeutics Inc stock below:
- Fulcrum Therapeutics Inc (FULC) is expected to reach an average price of $3.4501 in 2035, with a high prediction of $7.4495 and a low estimate of $3.0521. This indicates an $-46.05% rise from the last recorded price of $6.3954.
- Fulcrum Therapeutics Inc (FULC) stock is projected to chart a bullish course in 2040, with an average price target of $6.2404, representing an $-2.42% surge from its current level. The forecast ranges from a conservative $6.1891 to a sky-high $6.2004.
- Our analysts predict Fulcrum Therapeutics Inc (FULC) to jump 68.44% by 2045, soaring from $10.89 to an average price of $10.77, potentially reaching $10.92. While $10.89 is the low estimate, the potential upside is significant.
- Fulcrum Therapeutics Inc (FULC) stock is expected to climb by 2050, reaching an average of $5.5956, a $-12.51% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.55 and $6.2256, respectively, highlighting the market's uncertainty.
Fulcrum Therapeutics Inc Stock (FULC) Year by Year Forecast
Fulcrum Therapeutics Inc Stock (FULC) Price Forecast for 2025
Fulcrum Therapeutics Inc Stock (FULC) is expected to reach an average price of $9.9213 in 2025, with a high prediction of $17.54 and a low estimate of $2.3022. This indicates an +55.13% rise from the last recorded price of $6.3954.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $13.11 | $12.26 | $17.46 | +105.01% |
| July, 2025 | $2.8643 | $2.5716 | $13.70 | -55.21% |
| August, 2025 | $2.9399 | $2.3022 | $3.7499 | -54.03% |
| September, 2025 | $3.1704 | $2.8828 | $4.2552 | -50.43% |
| October, 2025 | $7.1687 | $3.1881 | $8.3357 | +12.09% |
| November, 2025 | $6.9192 | $4.9763 | $8.6826 | +8.19% |
| December, 2025 | $7.1575 | $6.6875 | $9.8422 | +11.92% |
Fulcrum Therapeutics Inc Stock (FULC) Price Forecast for 2026
The predicted value for Fulcrum Therapeutics Inc (FULC) in 2026 is set at an average of $15.69. Estimates vary from a peak of $28.85 to a trough of $2.5321, indicating an +145.34% surge from the present price of $6.3954.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $6.5281 | $6.1028 | $9.7604 | +2.07% |
| February, 2026 | $8.1086 | $6.0957 | $11.24 | +26.79% |
| March, 2026 | $6.8292 | $6.4392 | $10.47 | +6.78% |
| April, 2026 | $7.0174 | $6.077 | $8.0198 | +9.73% |
| May, 2026 | $5.228 | $5.138 | $7.5451 | -18.25% |
| June, 2026 | $4.2186 | $3.6583 | $5.6257 | -34.04% |
| July, 2026 | $5.2968 | $3.9962 | $6.5039 | -17.18% |
| August, 2026 | $18.63 | $2.5321 | $21.26 | +191.26% |
| September, 2026 | $22.39 | $16.53 | $25.63 | +250.03% |
| October, 2026 | $24.09 | $21.04 | $28.85 | +276.62% |
| November, 2026 | $17.89 | $17.78 | $24.64 | +179.68% |
| December, 2026 | $10.34 | $9.755 | $18.74 | +61.60% |
Fulcrum Therapeutics Inc Stock (FULC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Fulcrum Therapeutics Inc (FULC) is $10.44, with a high forecast of $20.79 and a low forecast of $0.0873. This indicates an +63.25% increase from the last price of $6.3954.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $13.97 | $8.0403 | $14.23 | +118.37% |
| February, 2027 | $8.8362 | $8.046 | $14.81 | +38.16% |
| March, 2027 | $6.1444 | $5.9144 | $9.0238 | -3.92% |
| April, 2027 | $11.97 | $5.272 | $12.74 | +87.24% |
| May, 2027 | $19.74 | $11.20 | $20.28 | +208.59% |
| June, 2027 | $4.6638 | $4.1338 | $20.79 | -27.08% |
| July, 2027 | $3.1844 | $2.9214 | $5.3314 | -50.21% |
| August, 2027 | $1.2349 | $0.0873 | $4.7697 | -80.69% |
| September, 2027 | $1.7432 | $0.7626 | $2.1932 | -72.74% |
| October, 2027 | $4.0637 | $1.6208 | $5.4937 | -36.46% |
| November, 2027 | $4.5043 | $3.189 | $4.8843 | -29.57% |
| December, 2027 | $3.7326 | $3.0757 | $5.717 | -41.64% |
Fulcrum Therapeutics Inc Stock (FULC) Price Forecast for 2028
In 2028, Fulcrum Therapeutics Inc (FULC) is projected to reach an average price of $5.6831, with a high projection of $11.35 and a low estimate of $0.0189. This indicates an -11.14% fall from the last price of $6.3954.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.0431 | $1.1928 | $4.0802 | -68.05% |
| February, 2028 | $3.1437 | $1.8708 | $4.0811 | -50.84% |
| March, 2028 | $3.6119 | $1.4267 | $4.1219 | -43.52% |
| April, 2028 | $9.2325 | $2.9796 | $11.35 | +44.36% |
| May, 2028 | $2.0607 | $1.7008 | $10.47 | -67.78% |
| June, 2028 | $0.1187 | $0.1987 | $3.0687 | -98.14% |
| July, 2028 | $1.1281 | $0.511 | $0.9481 | -82.36% |
| August, 2028 | $0.2499 | $0.3761 | $0.7704 | -96.09% |
| September, 2028 | $0.3643 | $0.4793 | $0.4646 | -94.30% |
| October, 2028 | $0.1213 | $0.2587 | $0.2816 | -98.10% |
| November, 2028 | $0.5495 | $0.0189 | $1.0616 | -91.41% |
| December, 2028 | $2.1601 | $0.2922 | $3.0225 | -66.22% |
Fulcrum Therapeutics Inc Stock (FULC) Price Forecast for 2029
The 2029 price forecast for Fulcrum Therapeutics Inc Stock (FULC) is $5.3065 on average, with a high prediction of $10.57 and a low estimate of $0.0382. This represents an -17.03% decrease from the previous price of $6.3954.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.1083 | $0.6456 | $2.9954 | -82.67% |
| February, 2029 | $0.1211 | $0.1611 | $1.146 | -98.11% |
| March, 2029 | $0.8795 | $0.0382 | $1.2868 | -86.25% |
| April, 2029 | $1.7101 | $0.8871 | $2.0111 | -73.26% |
| May, 2029 | $3.8983 | $1.1577 | $4.7483 | -39.05% |
| June, 2029 | $4.5789 | $3.4536 | $4.9389 | -28.40% |
| July, 2029 | $7.0694 | $4.2765 | $7.9194 | +10.54% |
| August, 2029 | $6.3377 | $5.7477 | $10.57 | -0.90% |
| September, 2029 | $4.0683 | $3.5906 | $6.5053 | -36.39% |
| October, 2029 | $3.4406 | $1.61 | $5.50 | -46.20% |
| November, 2029 | $0.0283 | $0.8712 | $4.5959 | -99.56% |
| December, 2029 | $1.4271 | $0.2627 | $1.9876 | -77.69% |
Fulcrum Therapeutics Inc Stock (FULC) Price Forecast for 2030
Fulcrum Therapeutics Inc Stock (FULC) is expected to reach an average price of $6.5157 in 2030, with a high forecast of $12.98 and a low forecast of $0.0528. This signifies an +1.88% surge from the last price of $6.3954.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.7006 | $3.0918 | $4.7606 | -10.86% |
| February, 2030 | $3.2495 | $4.1648 | $3.9154 | -49.19% |
| March, 2030 | $1.8617 | $0.4817 | $5.1464 | -70.89% |
| April, 2030 | $6.9878 | $1.1923 | $9.2375 | +9.26% |
| May, 2030 | $7.3743 | $5.1181 | $12.98 | +15.31% |
| June, 2030 | $9.0904 | $4.6299 | $11.32 | +42.14% |
| July, 2030 | $1.3669 | $0.1263 | $9.5557 | -78.63% |
| August, 2030 | $0.9281 | $0.0528 | $3.3228 | -85.49% |
| September, 2030 | $6.9992 | $1.6933 | $10.31 | +9.44% |
| October, 2030 | $9.9557 | $5.6245 | $12.37 | +55.67% |
| November, 2030 | $9.8368 | $7.4715 | $12.74 | +53.81% |
| December, 2030 | $7.578 | $5.7077 | $10.13 | +18.49% |
3.48%
1.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):